Navigation Links
Novocell Receives a Disease Team Award for $20 Million from the California Institute for Regenerative Medicine to Develop a Stem Cell Therapy for the Treatment of Diabetes
Date:10/28/2009

SAN DIEGO, Oct. 28 /PRNewswire/ -- Novocell, Inc., a preclinical stage diabetes company, today announced that it will receive a Disease Team award totaling $20 million from the California Institute for Regenerative Medicine (CIRM). The Disease Team includes a group of scientists at the University of California, San Francisco (UCSF), led by Dr. Jeff Bluestone, which is contracted to receive $2.8 million. The funding will advance Novocell's development of a first in kind cellular therapy for the treatment of diabetes.

Novocell's proposal was selected for funding by CIRM's governing board, the Independent Citizens Oversight Committee (ICOC), with advisement from the Scientific and Medical Research Funding Working Group. "Novocell's proposal addresses an unmet medical need, contains compelling preliminary data in animals and is backed by a high quality team of scientists. It is the expectation that all Disease Team award recipients will be entering the clinic after the funding period. Novocell's systematic approach is expected to do just that, and as a consequence, CIRM and the ICOC decided to fund Novocell's efforts," said Allan Trounson, President of CIRM.

Nearly 25 million people in the United States are afflicted with diabetes. Many diabetics have loss of insulin secreting cells resulting in poor blood sugar regulation. Novocell is developing an alternative to insulin injections by producing cells that will secrete insulin in patients similar to the cells that were lost. "We thank California voters for approving Proposition 71, and CIRM and the ICOC for their support of our science and scientists. This award will substantially accelerate our progress, which will benefit millions of Americans," said John West, President & Chief Executive Officer of Novocell.

"We are grateful for the confidence in our scientific team and the continuing financial support of our developm
'/>"/>

SOURCE Novocell, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2

Related biology technology :

1. Novocell Reports Successful Use of Stem Cells to Generate Insulin in Mice
2. Novocell Appoints Orville G. Kolterman, M.D. to Board of Directors
3. Novocell Announces Discovery Linking Key Cancer Cell Signaling Pathways With Proliferation and Self-Renewal of Human Embryonic Stem Cells
4. AEterna Zentaris Receives US$5.5 Million from Institutional Investors
5. Quotient Biodiagnostics Receives U.S. Food & Drug Administration Clearance To Enter U.S. Transfusion Diagnostics Market
6. Athera Receives Allowance of Two Key Patents
7. Sinovac Receives Certificate of Approval to Distribute Panflu (H5N1) Vaccine in Hong Kong
8. AMT Receives EMEA Orphan Drug Designation for Duchenne Muscular Dystrophy
9. CryoLife Receives Humanitarian Use Device Designation for SynerGraft(R) Processed Human Aortic Heart Valves
10. Hugh Tilson Receives Leadership Award at Pacific Drug Safety Summit
11. ThermoGenesis Receives Notice Related to Nasdaq Minimum Closing Bid Price Rule
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/11/2009)... ROCKVILLE, Md., Dec. 11 EntreMed, Inc. ... of $1.7 million in royalty revenue from sales ... estimated royalty revenue of $3.3 million. In ... quarter and projected revenue for fiscal 2009. ... the third quarter will be reflected in the ...
(Date:12/11/2009)... Therapeutics, Inc., a biopharmaceutical company focused on improving ... cardiovascular and muscle disease, today announced the publication ... crucial role in the progression of amyotrophic lateral ... neuromuscular synaptic regeneration in mice. The findings, ... journal Science , reveal miR-206 as a ...
(Date:12/11/2009)... College researchers have observed the "hot electron" effect in ... harvested the elusive charges using ultra-thin solar cells, opening ... authors report in the current online edition of ... in solar cells, it generates free electrons in a ... these charges, the electrons must reach the bottom of ...
(Date:12/11/2009)... OSLO, December 11 Algeta ASA ... the first clinical center in the,US, the ... randomizing patients,in the phase III clinical study ... as hormone-refractory) prostate cancer,(CRPC) that has metastasized ... The ALSYMPCA (ALpharadin in SYMptomatic Prostate ...
Breaking Biology Technology:EntreMed Reports Receipt of Third Quarter Royalty Payment 2miRagen announces discovery of key microRNA implicated in Lou Gehrig's disease 2Elusive 'hot' electrons captured in ultra-thin solar cells 2Algeta Announces First US Patient Randomized in ALSYMPCA Phase III Study at Tulane Cancer Center, New Orleans 2Algeta Announces First US Patient Randomized in ALSYMPCA Phase III Study at Tulane Cancer Center, New Orleans 3Algeta Announces First US Patient Randomized in ALSYMPCA Phase III Study at Tulane Cancer Center, New Orleans 4
... ... ... pharmaceuticals company, today announced,that it had successfully closed a third ... developing its unique,CriticalMix delivery technology and matching pipeline of candidate ...
... developed a new type of small-scale electric power generator ... and releasing of zinc oxide wires encapsulated in a ... , The new "flexible charge pump" generator is the ... by using the piezoelectric properties of zinc oxide structures ...
... Hoex and research group Plasma & Materials Processing (PMP) ... been awarded the Leverhulme Technology Transfer Award 2008. They ... 63,000 for the research group) for their successful transfer ... year Hoex,s Ph.D. research was rewarded with the SolarWorld ...
Other Biology Technology:Critical Pharmaceuticals Raise GBP650K 2Critical Pharmaceuticals Raise GBP650K 3New small-scale generator produces alternating current by stretching zinc oxide wires 2New small-scale generator produces alternating current by stretching zinc oxide wires 3TU/e awarded for knowledge transfer to solar energy industry 2
(Date:12/15/2009)... Economics, environmental impacts, social dynamics, and production ... overall success of an agroecosystem. Positive or negative, ... individuals and social groups to continuously adapt farming ... , Experiential learning theory suggests that knowledge is ... Such lessons are especially valuable for environmental and ...
(Date:12/15/2009)... is available in German ., Despite ... across the globe, cultures vary as to how space ... not use egocentric terms such as ,left, right, front, ... notions like ,north, south, east, west, at all times ... bowl" or "There is an snake by your Northern ...
(Date:12/15/2009)... toll on society. It is estimated that 100 to ... waters and it,s likely that rip currents account for more ... between rip current research and public understanding. Rip currents ... importantly, most people do not know how to even identify, ... of the Rip Current Symposium is to identify advancements in ...
Breaking Biology News(10 mins):Experiential learning teaches change and adaptation 2More than a jump to the left 2The Nations Mayors Commend House Passage of Health Reform Bill 60932 1The Nations Mayors Commend House Passage of Health Reform Bill 60932 2Findings show nanomedicine promising for treating spinal cord injuries 10653 1Findings show nanomedicine promising for treating spinal cord injuries 10653 2Findings show nanomedicine promising for treating spinal cord injuries 10653 3College Invites Public to Explore Career Options in Health Care 60926 1College Invites Public to Explore Career Options in Health Care 60926 2
... scientists have struggled to understand the decline and slow ... prized game and food fish native to New England ... salmon in the U.S. and Canada, but specific causes ... tags and associated technology may provide some answers. ...
... Platelets those tiny, unassuming cells that cause blood to ... play an important early role in promoting cerebral malaria, an ... many as half a billion people in tropical and subtropical ... the parasite responsible for it, Plasmodium, among the most studied ...
... researchers have developed a new gene silencing technology that ... to the development of certain diseases. This technology could ... plays a role. The groundbreaking research was led by ... of Structural and Chemical Biology at Mount Sinai School ...
Other Biology News:Signals from the Atlantic salmon highway 2Signals from the Atlantic salmon highway 3Signals from the Atlantic salmon highway 4Johns Hopkins scientists discover what drives the development of a fatal form of malaria 2
...
...
Healthy animals 10-32 weeks of age, mixed gender and breed; collected on wet ice following USDA guidelines, using Alsevers solution at 1:2 dilution...
... The Zero Blunt TOPO ... the fastest and easiest ... than or equal to95%) ... products amplified with proofreading ...
Biology Products: